moderate - Consulting segment is cyclical and sensitive to enterprise IT spending budgets, which contract during recessions as CFOs delay digital transformation projects. However, Software (52% of revenue) has recurring subscription characteristics with 90%+ renewal rates, providing stability. Infrastructure is counter-cyclical in some aspects: banks upgrade mainframes during stress periods for risk management and regulatory compliance. Overall, IBM's revenue declined only 5% during 2020 COVID shock, demonstrating relative resilience compared to pure-play consulting firms.

Rising rates have mixed impact. Negative: IBM carries $53B in debt (2.06x D/E), so higher rates increase interest expense by ~$200-300M annually per 100bps move, pressuring net margins. Positive: IBM's customer base (banks, insurers) benefits from higher rates through improved net interest margins, which can increase their IT budgets. Additionally, IBM's $130B+ pension obligation benefits from higher discount rates, reducing pension expense. Valuation multiple compression from rising rates is moderate given IBM trades at 17.3x EV/EBITDA (not extreme growth multiple).

value/dividend - IBM offers 3.5% dividend yield with 28-year consecutive increase streak, attracting income-focused investors. The stock trades at 3.6x P/S (below MSFT's 12x, ORCL's 6x), appealing to value investors betting on hybrid cloud/AI transformation. However, 1.2% 1-year return and -13.9% 3-month decline reflect skepticism about growth reacceleration. Not a momentum stock given single-digit revenue growth.